Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation

Pediatric Nephrology

Volumn 25, Issue 3, 2010, Pages 529-534

  Cara Fuentes, Gabriel M ^a   Garcia Meseguer, Carmen ^a   Pena Carrion, Antonia ^a   Melgosa Hijosa, Marta ^a   Garcia Pose, Araceli ^a   Alonso Melgar, Angel ^a   Navarro Torres, Mercedes ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Cyclosporin; Focal segmental glomerulosclerosis; Plasmapheresis; Recurrence; Renal transplantation

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PODOCIN; TACROLIMUS; THYMOCYTE ANTIBODY; ANTIINFLAMMATORY AGENT; CYCLOSPORIN;

AGE DETERMINATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; NEPHRECTOMY; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PEDIATRICS; PERITONEAL DIALYSIS; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; SINGLE DRUG DOSE; SURGICAL RISK; SURVIVAL RATE; TREATMENT DURATION; ADOLESCENT; ADULT; CHRONIC KIDNEY FAILURE; GRAFT REJECTION; KIDNEY; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; NEPHRECTOMY; PLASMAPHERESIS; PROTEINURIA; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950352064     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1361-0     Document Type: Article

References (36)

1. NAPRTCS (2007) Annual Report. Available at https://web. emmes.com/study/ped/annlrept/annlrept2007.pdf
2. Dall'Amico R, Ghiggeri G, Carrazo M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F (1999) Prediction and treatment of recurrent FSGS after renal transplantation in children. Am J Kidney Dis 34:1048-1055
3. Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2(12 Suppl):S258-S263
4. Hubsch H, Montané B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G (2005) Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol 20:210-216 (Pubitemid 40174037)
5. Sharma M, Sharma R, McCarthy E, Savin V (1999) "The FSGS factor": enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10:552-561 (Pubitemid 29117637)
6. Savin V, Sharma R, Sharma M, McCarthy E, Swan U, Ellis E, Lovell H, Warady B, Gunwar R, Chonko A, Artero M, Vincenti F (1996) Circulating factor with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883 (Pubitemid 26107345)
7. Greenstein S, Delrio M, Ong E, Feuerstein D, Schechner R, Kim D, Corey H, Kaskel R, Tellis V, Moritz M (2000) Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 14:1061-1065
8. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K (2001) Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of FSGS in children. Transplantation 71:628-633
9. Belson A, Yorgin P, Al-Uzri A, Salvatierra O, Higgins J, Alexander S (2001) Long term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 16:985-989 (Pubitemid 34026707)
10. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidneytransplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14 (Pubitemid 24018610)
11. Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574-581 (Pubitemid 24109121)
12. Weber S, T̈nshoff B (2005) Recurrence of focal-segmental glomerulosclerosis in children renal transplantation: clinical and genetics aspects. Transplantation 80(Suppl):S128-S134 (Pubitemid 41552923)
13. Reidy K, Kaskel FJ (2007) Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol 22:350-354 (Pubitemid 46766756)
14. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, Sanna-Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314-1321 (Pubitemid 36637988)
15. Jungraithmayr T, Cochat P, Fargue S, Hofer K, Knueppel T, Cortina G, Neuhaus T, Seeman T, T̈nshoff B, Winn MP, Zimmerhackl LB, for the ECoFTS (2007) Role of NPHS2 and TRPC6 in recurring focal segmental glomerulosclerosis: results from the European Collaborative FSGS Transplantation Study. J Am Soc Nephrol 18:SU-FC121
16. Caridi G, Perfumo F, Ghiggeri GM (2005) NPHS2 (Podocin) mutations in nephritic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57:54R-61R (Pubitemid 40593246)
17. Abitbol C, Zilleruelo G, Freundlich M, Strauss J (1990) Quantification of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic syndrome. J Pediatr 116:243-247 (Pubitemid 20056779)
18. Seikaly MG (2004) Recurrence of primary disease in children after renal transplantation: an evidence-based update. Pediatr Transplant 8:113-119 (Pubitemid 38508421)
19. Newstead CG (2003) Recurrent disease in renal transplant. Nephrol Dial Transplant 18:68-74
20. Cochat P, Fargue S, Liutkus A, Ranchin B (2006) Récidive du syndrome néphrotique après transplantation renale. Courr Transplant 6:154-160
21. Fujisawa M, Iijima K, Ishimura T, Higuchi A, Isotani S, Yoshiya K, Arakawa S, Hamami G, Matsumoto O, Yoshikawa N, Kamidono S (2002) Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 17:165-168 (Pubitemid 36076028)
22. Bartosh SM, Stablein DM, Fine RN (2004) Recurrence of focal segmental glomerulosclerosis (FSGS) following pediatric kidney transplantation in the modern immunosuppression era: a report from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Submitted for presentation at the American Transplant Congress, Boston, Massachusetts, 15-19 May 2004
23. Odorico JS, Knechtle SJ, Rayhill SC, Pirsch JD, D'Alessandro AM, Belzer FO, Sollinger HW(1996) The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61:228-234
24. Jungraithmayr T, Clara A, Zimmerhackl L (2005) Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation: results of the European Collaborative FSGS transplantation study group (ECOFTS). Pediatr Transplant Suppl 6:48
25. Baum MA (2004) Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 8:329-333 (Pubitemid 39062113)
26. Raafat R, Travis LB, Kalia A, Diven S (2000) Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 14:189-194 (Pubitemid 30122139)
27. Sheth RD, Kale AS, Glodstein SL, Brewer ED (2001) Rapid recurrence of post-transplant FSGS in pediatric patients after daclizumab induction. Pediatr Nephrol 16:C190
28. De la Cerda Ojeda F, Fijo López-Viota J, Martín Govantes J (2007) Trasplante renal en niños con glomeruloesclerosis focal y segmentaria. Actualizaciones en Trasplantes 2007:251-253
29. Gagnadoux MF (2002) Ask the expert. Does antibody induction therapy with daclizumab or basiliximab increase the risk of recurrence of post-transplant focal segmental glomerulosclerosis? Pediatr Nephrol 17:305
30. Westphal S, Hansson S, Mj̈rnstedt L, M̈lne J, Swerkersson S, Friman S (2006) Early recurrence of nephritic syndrome (immunoglobulin M nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin and rituximab. Transplant Proc 38:2659-2660 (Pubitemid 44693649)
31. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20:1660-1663 (Pubitemid 41554486)
32. Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M (2008) Rituximab for post-transplant recurrences of FSGS. Pediatr Transplant 13:240-243
33. Garcia CD, Bittencourt VB, Tumelero A, Antonello JS, Malheiros D, Garcia VD (2006) Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc 36:1904-1906 (Pubitemid 44190082)
34. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF (1999) Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 14:2650-2656 (Pubitemid 32208381)
35. Salomon R, Gagnadoux MF, Niaudet P (2003) Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 27:810-814 (Pubitemid 36373453)
36. Raafat RH, Kalia A, Travis LB, Diven SC (2004) High-dose oral cyclosporine therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 44:50-56 (Pubitemid 38880926)